MDGeneticPro BRCA1 & BRCA2

Discover the Hereditary Risk for Breast Cancer.

Combating Breast Cancer. Together.

According to the National Breast Cancer Foundation, 1 in 8 women will develop breast cancer in her lifetime. On average, every 2 minutes a women is diagnosed with breast cancer in the US. These statistics continue to be alarming, but hereditary breast cancer screening can help detect the risk for both women and men.

With a simple blood draw, our advanced BRCA gene mutation testing identifies harmful variants in the BRCA1 or BRCA2 genes. We offer quick turnaround times with results in just 15 days.

Discover the risk. Live with confidence.

    In 2022, an
    estimated 287,500 new cases of invasive breast cancer will be diagnosed in women in the U.S according to the National Breast Cancer Foundation.
    The National Breast Cancer Foundation estimates 2,710 men will be diagnosed with breast cancer in US.

    Let’s Talk

    We want to hear from you! Tell us more about your interest in MDChemistryPro today.

    [gravityform id="65" description="false" ajax="true"]

    Read Our Blog

    Labs Like Premier Medical Laboratory Services Now Seeing Increased Demand for Various Molecular Diagnostic Tests

    Labs Like Premier Medical Laboratory Services Now Seeing Increased Demand for Various Molecular Diagnostic Tests

    ~As social distancing measures have decreased, demand for medical tests other than COVID-19 increase~ GREENVILLE, SC September 23, 2020  – At the onset of the pandemic the nation began to practice social distancing, and subsequently, many stopped scheduling visits...

    read more